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Persistent organochlorine (OC) contaminants
were first detected in breast milk in the early
1950s (Laug et al. 1951). Although many OCs
were restricted in North America and Europe
during the 1970s, specific requirements such as
the control of malaria with 1,1,1-trichloro-2,2-
bis(p-chlorophenyl)ethane (p,p´-DDT) or
hexachlorocyclohexanes (HCHs) remain in
some parts of the world. Although polychlori-
nated biphenyls (PCBs), predominantly indus-
trial chemicals, were also banned in many
countries in the 1970s, these are still present
in the environment, and uncertainties exist
regarding their current distribution (Breivik
et al. 2004). Human tissue levels of PCBs and
p,p’-DDT peaked in the 1970s but, probably
because of restrictions on use, are now decreas-
ing (Norén and Meironyté 2000). In contrast,
polybrominated diphenyl ether (PBDE) levels,
first detected in breast milk in 1972, have been
increasing throughout the 1980s and 1990s
(Meironyté et al. 1999; Norén and Meironyté
2000; Solomon and Weiss 2002).
Brominated diphenyl ethers (BDEs) are
commercially available as pentabromodiphenyl
ether (pentaBDE), octabromodiphenyl 
ether (octaBDE), and decabromodiphenyl
ether (decaBDE), all of which have different
PBDE profiles. DecaBDE is used in high-
impact polystyrene for electronic enclosures
and as a flame retardant in upholstery textiles
(Hardy 2002a). OctaBDE is used in business
equipment housings made of acrylonitrile–
butadiene–styrene (ABS) resins (Hardy 2002b).
PentaBDE is used as a flame retardant for
flexible polyurethane foam (Hardy 2002b). As
additive flame retardants, PBDEs are used in
consumer items such as polyurethane foams,
television sets, computers, radios, textiles,
paints, and plastics. These brominated com-
pounds act in the gas phase of the fire by
reacting with free radicals generated during
combustion, thus terminating the reaction
(Rahman et al. 2001). PBDEs are dissolved in
materials, not covalently bonded. This has
led to suggestions that they leach out or
volatilize into the environment (McDonald
2002). PBDEs investigated in this study are
predominantly indicative of the pentaBDE
commercial product.
PBDEs, PCBs, and OCs are hydrophobic,
persistent chemicals that may bioaccumulate
through food chains. The main route of expo-
sure to PCBs or OCs in the general human
population is via the diet (Duarte-Davidson
and Jones 1994). In the case of PBDEs, the
relative importance of different exposure
routes remains obscure. It has been suggested
that exposure may occur mainly through the
consumption of PBDE-contaminated fish
(Meironyté et al. 1999). However, PBDEs do
appear to contaminate indoor human envi-
ronments (Jakobsson et al. 2002), giving rise
to the possibility of transfer via inhalation of
vapor-phase chemicals and chemicals attached
to indoor air/dust.
The human toxicity of PCBs and OCs is
well documented [World Health Organization
(WHO) 1993]. The toxic effects of PBDEs in
humans remain to be properly ascertained
(Hardy 2002b). Despite apparent similarities
in chemical structure between PBDEs and
PCBs, there are important three-dimensional
differences due to the ether linkage found in
the former (Hardy 2002a). Although currently
found to be lower than PCB levels in human
tissues, PBDE levels have been increasing
(Hites 2004; Norén and Meironyté 2000).
PBDEs, particularly congeners present in the
pentaBDE product, may possess toxic proper-
ties, including endocrine-disrupting activity
(Hallgren and Darnerud 2002) and interfer-
ence with brain development (Branchi et al.
2003), and there is also a suggested association
with incidence of non-Hodgkin lymphoma
(Darnerud et al. 2001). Some evidence exists
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Polybrominated diphenyl ether (PBDE) congeners are constituents of flame retardants, and there is
growing concern regarding their persistence, bioaccumulation, and toxicity. We collected breast milk
samples between late 2001 and early 2003 from 54 U.K.-resident mothers. Of these, 27 originated
from southeast England (London), and the other 27 originated from northwest England (Lancaster).
Analysis of milk-fat extracts by gas chromatography–mass spectrometry was performed to determine
the levels of 15 PBDE congeners, 15 polychlorinated biphenyl (PCB) congeners, and other selected
chlorinated compounds. PCB and organochlorine (OC) levels in southeast samples were consistently
higher, and significant differences (p < 0.05) were observed. ΣPBDE levels ranged from 0.3 to
69 ng/g lipid (geometric mean, 6.6 ng/g), and PBDE-47 was the most abundant congener. ΣPCB
levels ranged from 26 to 530 ng/g lipid (geometric mean, 150 ng/g) and were composed mainly of
PCB-153 (26%), PCB-138 (20%), and PCB-180 (13%). OC levels for 1,1,1-trichloro-2,2-
bis(p-chlorophenyl)ethane (p,p´-DDT) and its metabolites (ΣDDX) ranged from 24 to 2,300 ng/g
lipid (geometric mean, 160 ng/g); hexachlorobenzene ranged from nondetectable levels to 180 ng/g
lipid (geometric mean, 17 ng/g); and Σhexachlorocyclohexane levels ranged from 1.2 to 1,500 ng/g
lipid (geometric mean, 16 ng/g). Using nuclear magnetic resonance–based metabonomics, samples
(n = 7) containing the highest contaminant levels were compared with samples (n = 7) containing
the lowest levels. Excellent separation along the first principal component implied that the chemical
constituents of the two groups were significantly different. Although reasons for such differences
remain obscure, lifestyle factors associated with a more heterogeneous London cohort could be
responsible. Identifying primary routes of contaminant exposures and their biologic effects is of great
importance. Key words: breast milk, flame retardants, gas chromatography–mass spectrometry, milk-
fat extracts, organochlorines, PBDE-47, persistent contaminants, polybrominated diphenyl ethers,
polychlorinated biphenyls, United Kingdom. Environ Health Perspect 112:1085–1091 (2004).
doi:10.1289/ehp.6991 available via http://dx.doi.org/ [Online 21 April 2004]
of PBDE carcinogenicity in animal bioassays,
but the results of these studies remain at best
unequivocal (Hardy 2002b; McDonald 2002).
A current profile of PBDE congeners in
U.K. breast milk (as measured in extracts of
milk fat) in relation to other contaminants
remains to be established (Kalantzi et al. 2003).
In the present study, our primary objective
was to report in detail current U.K. PBDE
levels (associated with the pentaBDE prod-
uct) and, in the same samples, to relate these
to current and temporal PCB and OC levels
of the United Kingdom. The samples from
which milk-fat extracts were obtained origi-
nated from London in the southeast and
Lancaster in the northwest. We also investi-
gated whether nuclear magnetic resonance
(NMR)–based metabonomics (Nicholson
et al. 1999), combining high-resolution NMR
spectroscopy with pattern recognition, might
be a potential platform to study the chemical
constituents of milk-fat extracts shown to
contain different contaminant profiles. This
methodology allows the identification, quan-
tification, and cataloguing of time-related
changes in integrated biologic systems and
thus may be employed to screen for profiles in
tissue extracts (Lindon et al. 2003; Nicholson
et al. 1999; Viant et al. 2003). Finally, we con-
sider whether the quantification of such conta-
minants in biologic matrices remains sufficient,
or whether it is more appropriate to analyze
their biologic effects, either individually or as
complex mixtures.
Materials and Methods
Sample collection. Individual breast milk sam-
ples from U.K.-resident women, donated
anonymously and without criteria (i.e., no prior
selection or bias), were obtained with appropri-
ate ethical approval. A total of 54 samples were
collected between late 2001 and January 2003
from the maternity units of hospitals based in
the Lancaster (northwest England; n = 27, via a
neonatal unit) and London (southeast England;
n = 27, via a milk bank) regions. Donor ages
ranged from 24 to 34 years, and milk samples
(≈100 mL from a single expression; in a small
number of cases, samples expressed on differ-
ent days were donated) were collected by man-
ual expression into sterile collection bottles.
Samples were immediately frozen and stored at
–20°C before analysis.
Donors originating from Lancaster com-
pleted simple lifestyle questionnaires; such
information was not available for London
samples. Lancaster samples were donated
within the first month of parturition, several
being donated within the first 2–3 days. From
the information obtained on Lancaster sam-
ples, it was noted that all but two donors were
nonsmokers, and cumulative past lactation
ranged from 0 to 21 months. All consumed
meat, a healthy amount of fresh fruit, and low
amounts of alcohol (five donors, 1–2 units/day;
one unit is defined as 7.9 g ethanol). Lifestyle
data thus collected were not found to correlate
with the levels of contaminants measured (data
not shown). In the absence of more details, it is
difficult to comment on similarities or differ-
ences between the two cohorts originating
from the London or Lancaster regions.
However, experience would suggest that no
marked differences in range of socioeconomic
class, outlets through which food might be
sourced, age, or parity would exist. Although
the London cohort would be envisaged to be a
more heterogeneous population with an input
from foreign donors, this was not expected to
have an overwhelming influence.
Extraction of milk for PBDE and PCB/OC
analyses. All solvents were of HPLC or glass-
distilled grade. Silica gel (0.063–0.200 mm;
Merck, Poole, U.K.) and Na2SO4 were heated
at 450°C overnight and stored in sealed
containers. Standards were purchased from
Promochem (Welwyn Garden City, U.K.) and
QMx (Thaxted, U.K.).
After thawing, milk samples that originated
from a single expression were centrifuged at
3,000 rpm for 15 min. After separation of the
milk-fat layer from the aqueous phase, a mix-
ture of milk fat (0.5 g), Na2SO4 (5 g), and
hexane (50 mL) was boiled for 10 min and
allowed to cool before lipid determination.
Evaporated to 5 mL, these mixtures were
applied to 25-mm inner-diameter columns
containing 15 g acidified silica gel (2:1 silica
gel:acid by weight) and eluted with hexane.
Eluted samples were evaporated to 1 mL under
a gentle stream of nitrogen and applied to gel
permeation chromatography columns packed
with Biobeads S-X3 (Biorad Laboratories,
Hercules, CA, USA) and eluted with hexane:
dichloromethane (1:1 by volume). 13C12-
labeled PCB and dioxin recovery standards
(added at the beginning of the procedure) and
internal standards (added at the end of the pro-
cedure) in dodecane were incorporated when
subsequent gas chromatography–mass spec-
trometry (GC-MS) analysis was carried out on
whole milk-fat extracts but were excluded
when extracts were generated for subsequent
1H-NMR spectroscopy.
Gas chromatography for PBDE analysis
was performed on a Finnigan Trace GC2000
series gas chromatograph equipped with a 30-m
DB-5MS 0.25-mm inner-diameter capillary
column (J&W Scientific, Stockport, U.K.) fit-
ted with a retention gap (2 m long, 0.53 mm
inner diameter). Sample aliquots (2 µL) were
injected by a Thermoquest AS2000 auto-
injector (Finnigan, Hemel Hempstead, U.K.),
with the injection port at 270°C, in splitless
mode, with 100 kPa pressure surge. The carrier
gas was helium at a flow rate of 1 mL/min.
The oven temperature program was as fol-
lows: 80°C for 2 min, 25°C/min to 200°C,
4°C/min to 315°C, and 315°C for 10 min.
The quadrupole TRACE mass spectrometer
(Finnigan) was set in selected ion recording
mode, in negative ion chemical ionization
(CI–) mode, using ammonia as the reagent
gas, a source temperature of 200°C, interface
temperature of 315°C, and electron energy of
70 eV. The following PBDE congeners, cho-
sen because of their reported occurrence in
environmental samples, were screened: PBDE
congeners 17, 28, 32, 35, 37, 47, 49, 71, 75,
85, 99, 100, 119, 153, and 154. Of these,
congeners 28, 47, 99, 100, 153, and 154 were
regularly detected in the milk samples.
Gas chromatography for PCB and OC
analysis was performed on a Fisons GC8000
series gas chromatograph (Fisons, Manchester,
U.K.) equipped with a 50-m CPSil8 0.25-mm
inner-diameter capillary column (Chrompak,
Walton-on-Thames, U.K.), fitted with a reten-
tion gap as for PBDE analysis. Sample aliquots
(2 µL) were injected, with the injection port at
250°C, in splitless mode. The carrier gas was
helium with a flow rate of 1 mL/min. The
oven temperature program was as follows:
100°C for 2 min, 20°C/min to 140°C,
4°C/min to 200°C, 200°C for 13 min,
4°C/min to 300°C, and 300°C for 10 min.
The quadrupole MD800 mass spectrometer
(Fisons) was set in selected ion recording
mode, in electron impact positive ion ioniza-
tion (EI+) mode, with a source temperature of
250°C, interface temperature of 300°C, and
electron energy of 70 eV. A screen for the fol-
lowing PCB congeners and OC pesticides was
carried out: PCB congeners 18, 22, 28, 31,
41/64, 44, 49, 52, 54, 60/56, 70, 74, 87,
90/101, 95, 99, 104, 105, 110, 114, 118,
123, 132, 138, 141, 149, 151, 153, 155, 156,
157, 158, 167, 170, 174, 180, 183, 187, 188,
189, 194, 199, 203; α-HCH, β-HCH,
γ-HCH, δ-HCH, hexachlorobenzene (HCB),
α-chlordane, γ-chlordane, o,p´-dichloro-
diphenyldichloroethane (DDD), p,p´-DDD,
o,p´-dichlorodiphenyldichloroethylene (DDE),
p,p´-DDE, o,p´-DDT, and p,p´-DDT. The
following were regularly detected in the milk
samples: PCB congeners 41/64, 44, 49,
60/56, 70, 74, 87, 90/101, 95, 99, 105, 110,
114, 118, 138, 149, 151, 153, 156, 157, 158,
167, 170, 180, 183, 187, 189, 194, 203;
α-HCH, β-HCH, γ-HCH, HCB, p,p´-DDD,
o,p´-DDE, p,p´-DDE, and p,p´-DDT.
A seven-point calibration was used for
quantifying all PBDEs, PCBs, and OCs.
Detection limits were defined as three times
the standard deviation of the levels found in
the analytical blanks or the instrument detec-
tion limit in the absence of detectable levels in
the blanks.
Quality assurance/quality control. Milk
samples were analyzed in batches of six. Along
with each batch a blank sample was included,
and with every third batch an in-house 
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reference material (a butter sample) was also
extracted. This reference material had been
analyzed on 12 separate occasions before these
analyses and was considered a useful deter-
minant of the reproducibility and rigorous
nature of the analytical procedure employed.
A control chart was employed to identify
the mean and warning limits (defined as plus
two times the standard deviation of the average
concentration found in the 12 reference mater-
ial samples previously analyzed) of the reference
materials analyzed throughout the study. The
comparison quantity was defined as the sum of
the levels of PBDE-47, PBDE-99, PBDE-100,
PBDE-153, and PBDE-154 in the reference
butter sample. Seven reference material samples
were analyzed during the course of this study,
and the value of the sum of the five PBDEs
never exceeded the warning limits.
Recoveries ranged from 50 to 119%, with
an average of 90%. Extracted milk fat ranged
from 29 to 85% of centrifuged milk fat fresh
weight (mean, 55%). Centrifuged milk fat
fresh weight ranged from 0.7 to 5.7% (mean,
2%) of whole milk fresh weight.
1H-NMR spectroscopy. Extracts in hexane
were transported to Imperial College (London)
for analysis. Extracts of milk samples contain-
ing the lowest contaminant levels (n = 7, all
from Lancaster) were compared with extracts
of milk samples containing the highest levels
(n = 7, all from London). These two sets of
samples were chosen on the basis of the sum of
all contaminants. To these, an equal volume of
CDCl3 (99.9% deuterium; Sigma, Poole,
U.K.) was added, and samples were purged
with nitrogen gas. To ensure the removal of
hexane, this purge process was repeated twice.
Then samples were reconstituted in 500 µL of
CDCl3 and transferred into 5-mm NMR
tubes. 1H-NMR spectra were recorded on a
Bruker DRX600 NMR spectrometer, at 300
kelvin, with a 5-mm inverse probe using a stan-
dard one-dimensional pulse sequence [RD-90°-
t1-90°-tm-90°-acquisition]. The recycle delay
(RD) was 3 sec; mixing time, tm, 150 msec; t1,
3 µsec. The 90° pulse length was adjusted to
approximately 10 µsec. Transients (128) were
collected into 32,768 data points for each spec-
trum with the spectral width of 12 kHz.
Data reduction and principal components
analysis. All free induction decays were multi-
plied by an exponential function equivalent to
a 1 Hz line-broadening factor before Fourier
transformation. NMR spectra were then phase
and baseline corrected before being divided into
245 buckets, over the chemical shift range
0.2–10 ppm, using AMIX (Bruker Analytik,
Rheinstetten, Germany). Each bucket was
0.04 ppm wide, and the area in each region was
integrated. The regions δ6.8–δ7.5 ppm and
1.5–2.5 ppm containing residual solvents (chlo-
roform and water, respectively) were discarded.
The value of each bucket was normalized
relative to the total sum of the spectral integral
before principal components analysis (PCA),
which was carried out with the software
Simca-P 8.0 (Umetrics, Umeå, Sweden).
Results
PBDE congener levels in milk-fat extracts
obtained from U.K. breast milk samples (n =
54) obtained between late 2001 and January
2003 are shown in Table 1. ΣPBDE levels
ranged from 0.1 to 69 ng/g lipid, with a geo-
metric mean of 6.6 ng/g lipid (median,
6.3 ng/g lipid). PBDE-47 (geometric mean,
3 ng/g lipid; median, 2.7 ng/g lipid; 45% of
ΣPBDE content) was always the most abun-
dant congener present in breast milk. As a per-
centage of ΣPBDE content, other congeners
were found in the following order: PBDE-153
(21%) > PBDE-99 (14%) > PBDE-100
(9.0%) > PBDE-154 (7%), respectively.
Making up much smaller proportions of
ΣPBDE levels were PBDE congeners 28, 32,
35, 17, and 71.
Published levels of ΣPBDE congeners in
breast milk are shown in Table 2. Selected
congeners have been included in the ΣPBDE
values presented in Table 2 to facilitate com-
parisons with the results of different studies.
Compared with European and Japanese milk
samples, markedly higher (~10-fold) levels
appear to occur in U.S. milk samples. Current
ΣPBDE levels in U.K. milk samples, although
not as high as those found in U.S. milk sam-
ples, are still much higher than in milk samples
from other European countries and Japan. As a
consequence of stringent fire regulations since
1988, the United Kingdom has seen the use of
larger quantities of the pentaBDE mixture
than many of her European counterparts. The
United Kingdom is currently the fourth
largest PBDE producer in the world, with an
output of ~25,000 metric tons annually (Alaee
et al. 2003).
PCB levels in milk-fat extracts obtained
from U.K. breast milk are shown in Table 3.
ΣPCB levels ranged from 26 to 530 ng/g
lipid, with a geometric mean of 150 ng/g
lipid (median, 180 ng/g lipid). The most
commonly occurring PCB congeners were
found to be present in the following order:
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Table 1. PBDE congener levels in milk-fat extracts obtained from U.K. breast milk (n = 54), 2001–2003.
PBDE Geometric mean Median Minimum Maximum Percent samples
congener (ng/g lipid) (ng/g lipid) (ng/g lipid) (ng/g lipid) positive
17 0.1 ND ND 1 32
28 0.3 0.2 ND 2.1 89
32 0.1 ND ND 0.3 38
35 0.2 ND ND 0.6 28
37 0.4 ND ND 0.5 9
47 3 2.7 0.1 37 100
49 0.2 ND ND 0.9 11
71 0.2 ND ND 0.5 11
75 0.5 ND ND 0.6 4
85 0.5 ND ND 1.4 9
99 0.9 0.8 ND 13 92
100 0.6 0.5 ND 7 94
119 0.2 ND ND 0.4 11
153 1.4 1.3 ND 4.9 89
154 0.5 0.4 ND 2.5 81
ΣPBDE 6.6 6.3 0.3 69 —
Abbreviations: —, not applicable; ND, not detected. For raw data, see Supplemental Material online (http://ehp.niehs.
nih.gov/members/2004/6991/supplemental.pdf).
Table 2. A comparison of ΣPBDE levels in breast milk samples from different countries.
No. of samples Year of ΣPBDE PBDE congeners
Country analyzed sampling [ng/g, mean (range)] included in ΣPBDE Reference
Canada 10 1992 5.7 (0.7–28)a 28, 47, 99, 100, Ryan and Patry
153, 154 2000
Finland 11 1994–1998 2.3 (0.9–5.9) 28, 47, 99, 153 Strandman et al.
2000
Japan 12 NA 0.7–2.8 28, 47, 99, 100, Ohta et al. 2000
153, 154
Sweden 40 1997 4 28, 47, 66, 100, Norén and
99, 85, 153, 154 Meironyté 2000
United Kingdom 54 2001–2003 8.9 (0.1–63)a,b 47, 99, 100, 153, This study
154
United States 47 2001 73.9 (6.2–418.8) 17, 28, 47, 66, Schecter et al.
77, 85, 99, 100, 2003
138, 153, 154,
183, 209
NA, data not available.
aSum includes PBDE congeners listed only to facilitate interstudy comparisons. bArithmetic mean and concentration
range in ng/g lipid.
PCB-153 > PCB-138 > PCB-180 > PCB-170
> PCB-118 > PCB-187 > PCB-99 > PCB-156.
PCB-153 constituted some 26%, PCB-138
some 20%, and PCB-180 some 13% of
ΣPCB levels. A comparison of the results
from this study with previously reported
U.K. levels (Table 4) suggests that ΣPCB
levels are currently decreasing, probably as a
consequence of bans imposed on the use of
these contaminants.
Total HCB levels ranged from below the
detection limit to 180 ng/g lipid (geometric
mean, 17 ng/g lipid; median, 18 ng/g lipid),
whereas ΣHCH (defined as the sum of α-,
β-, and γ-HCH) levels ranged from 1.2 to
1,500 ng/g lipid (geometric mean, 16 ng/g
lipid; median, 18 ng/g lipid; Table 3). ΣDDX
(p,p´-DDT and its metabolites) levels ranged
from 24 to 2,300 ng/g lipid, giving rise to a
geometric mean of 160 ng/g lipid (median,
160 ng/g lipid). The most commonly occur-
ring isomers were p,p´-DDE (geometric mean,
150 ng/g lipid; median, 150 ng/g lipid; range,
20–1,600 ng/g lipid) and p,p´-DDT (geo-
metric mean, 6.2 ng/g lipid; median, 6.2 ng/g
lipid; range, 1.1–760 ng/g lipid). Of two milk
samples that exhibited exceptionally high
ΣDDX levels, one also exhibited exceptionally
high ΣHCH levels and the other exhibited
exceptionally high ΣHCB levels (data not
shown). Table 4 again demonstrates that levels
in U.K. breast milk of p,p´-DDE, HCB, and
β-HCH have been falling for some time.
Geometric means, medians, and ranges of
various contaminant concentrations in milk-fat
extracts obtained from breast milk samples
originating from the London region (n = 27)
and the Lancaster region (n = 27) are com-
pared in Table 5 and Figure 1A, B. The data
were log-transformed, and a t-test was used to
investigate differences in contaminant levels
between the samples from London and those
from the Lancaster region. Significantly higher
(p < 0.0001) levels of PBDE-47 were found in
London milk samples compared with those
originating from Lancaster, but no differences
were found in ΣPBDE and the levels of four
other PBDE congeners (Table 5, Figure 1B).
With regard to PCBs and OCs, significantly
higher (p < 0.05) levels of PCB-138, PCB-153,
PCB-180, ΣPCB, p,p´-DDE, ΣDDX, HCB,
β-HCH, and ΣHCH were found in milk sam-
ples from London (Table 5, Figure 1A). Breast
milk samples originating from London tended
to exhibit higher geometric mean levels for all
the contaminants analyzed in comparison with
Lancaster levels (Figure 1A, B).
1H-NMR spectra showed that the major
chemical constituents of extracts analyzed in
this study were lipids (data not shown). Taking
into account the remaining, unidentified
NMR signals, seven of the milk-fat extracts
shown to contain the lowest contaminant
levels (all from the Lancaster region) were
compared with seven extracts shown to con-
tain the highest levels (all from the London
region). NMR with pattern recognition meth-
ods gave rise to a multivariate PCA score plot
(Figure 2) in which each point represents an
individual extract. The observation that clus-
tering occurred based on contaminant levels
highlights the differences in the chemical
composition of these two groups of milk-fat
extracts. Excellent separation for the two
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Table 4. Temporal levels of selected compounds observed in U.K. breast milk and adipose fat samples.
Period of Mean No. of
sampling (ng/g lipid) Range samples Tissue source Reference
ΣPCB
1976–1977 600 100–1,500 81 Adipose fat U.K. MAFF 1983
1979–1980 500 100–2,100 102 Milk fat U.K. MAFF 1983
1990–1991 522 140–1,697 32 Milk fat Duarte-Davidson et al. 1994
2001–2003 200 26–530 54 Milk fat This study
p,p´-DDE
1969–1971 1,600 NA 85 Adipose fat Abbott et al. 1972
1976–1977 2,100 NA 81 Adipose fat Abbott et al. 1981
1979–1980 1,600 10–7,300 102 Milk fat Collins et al. 1982
1982–1983 1,300 50–5,100 187 Adipose fat Abbott et al. 1985
1997–1998 430 60–4,000 168 Milk fat Harris et al. 1999
2001–2003 220 22–1,600 54 Milk fat This study
HCB
1969–1971 50 10–290 85 Adipose fat Abbott et al. 1972
1976–1977 220 20–3,200 81 Adipose fat Abbott et al. 1981
1979–1980 140 10–1,000 102 Milk fat Collins et al. 1982
1982–1983 110 30–320 187 Adipose fat Abbott et al. 1985
1997–1998 43 12–333 168 Milk fat Harris et al. 1999
2001–2003 20 ND–180 54 Milk fat This study
β-HCH
1969–1971 260 NA 85 Adipose fat Abbott et al. 1972
1976–1977 330 NA 81 Adipose fat Abbott et al. 1981
1979–1980 220 10–4,400 102 Milk fat Collins et al. 1982
1982–1983 270 10–810 187 Adipose fat Abbott et al. 1985
1997–1998 68 8–750 168 Milk fat Harris et al. 1999
2001–2003 40 1.2–1,500 54 Milk fat This study
Abbreviation: NA, data not available; ND, not detected. 
aArithmetic mean in ng/g lipid.
Table 3. PCB and OC levels in milk-fat extracts obtained from U.K. breast milk (n = 54), 2001–2003.
Geometric Percent samples in
mean Median Minimum Maximum which contaminant
Contaminant (ng/g lipid) (ng/g lipid) (ng/g lipid) (ng/g lipid) detected
PCB-28 2.1 2.0 0.6 10 100
PCB-74 6.5 6.6 1.4 40 100
PCB-99 5.3 5.4 1.5 21 100
PCB-105 1.9 2.0 0.4 11 100
PCB-118 9.6 10 2.4 43 100
PCB-138 31 37 4.2 100 100
PCB-153 39.5 49 4.3 130 100
PCB-156 4.0 5.1 0.6 13 100
PCB-167 1.3 1.5 0.2 4.1 100
PCB-170 9.1 11 0.9 49 100
PCB-180 20 25 1.8 120 100
PCB-183 2.5 2.9 0.3 8.9 100
PCB-187 6.0 7.0 0.6 39 100
PCB-194 2.7 2.7 ND 27 94
PCB-203 2.2 2.4 ND 15 98
ΣPCB 150 180 26 530 —
α-HCH 0.2 ND ND 2 35
β-HCH 15 17 1.2 1,500 100
γ-HCH 0.8 0.6 ND 7.7 91
ΣHCH 16 18 1.2 1,500 —
HCB 17 18 ND 180 98
α-Chlordane 0.3 ND ND 1.4 11
o,p´-DDD 0.3 ND ND 0.9 4
o,p´-DDT 0.7 0.6 ND 55 80
o,p´-DDE 0.2 0.1 ND 5.8 69
p,p´-DDD 0.3 0.3 ND 11 82
p,p´-DDE 150 150 22 1,600 100
p,p´-DDT 6.2 6.2 1.1 760 100
ΣDDX 160 160 24 2,300 —
Abbreviations: —, not applicable; ND, not detected. For raw data, see Supplemental Material online (http://ehp.niehs.
nih.gov/members/2004/6991/supplemental.pdf).
groups of extracts was clearly evident along
the first principal component, thus implying
that the chemical constituents of both groups
are significantly different.
Discussion
The occurrence of PBDE-47 in breast milk
(Meironyté et al. 1999), human blood plasma
(Klasson-Wehler et al. 1997), and human
adipose tissue (She et al. 2000) has been
reported. In Sweden, a PBDE congener pat-
tern consisting of PBDE-47 > PBDE-99
> PBDE-153 > PBDE-100 > PBDE-154 in
terms of relative content has been noted,
whereas others have reported the presence
of equal levels of PBDE-99 and PBDE-153
(Darnerud et al. 1998; Meironyté et al. 1999).
Other studies from Japan, Sweden, the United
States, and now the United Kingdom (present
study) have found PBDE-153 to be present at
higher levels than PBDE-99 (Meironyté et al.
2003; Ohta et al. 2000; She et al. 2002).
Estimates of market demand for major
brominated flame retardants suggest that
some 58% of world market volume occurs in
Asia, followed by the Americas (26%) and
then Europe (14%) [Bromine Science and
Environmental Forum (BSEF) 2001]. Of
three commercial PBDE mixtures—pentaBDE,
octaBDE and decaBDE—the latter is the most
commonly found in Europe in recent years
with approximately 7,600 metric tons of
decaBDE in current use (BSEF 2001; Hardy
2002b). PBDE congeners 47, 99, 100, and
153 are all components of pentaBDE. It has
been tentatively suggested that since 1970
a cumulative sum of 3,000 metric tons of
pentaBDE may have been manufactured in the
United Kingdom (Alcock et al. 2003).
That lower brominated PBDEs are still
present in U.K. milk samples (Table 1) sug-
gests historical use of the pentaBDE product
still plays a role in determining current con-
gener patterns. It has been hypothesized that in
sand, soil, or sediment decaBDE photode-
grades and may to a minor degree give rise to
lower brominated congeners (Sellström et al.
1998; Söderström et al. 2004). Diet may be an
important route of exposure to PBDEs, partic-
ularly through the consumption of fish (Lind
et al. 2002). Whether diet is the dominant
route of uptake remains to be ascertained.
As PBDEs are used in indoor environ-
ments, the potential for transfer via inhalation
of indoor dusts is a possibility. Foam from
furniture and cars in the United Kingdom is
likely to have been treated with the technical
pentaBDE mixture profile in the past (Wilford
et al. 2003), and the possibility of PBDEs
volatilizing from foam has been previously
demonstrated (Wilford et al. 2003). The
pattern of PBDE congeners in U.K. breast
milk suggests higher PBDE-47, PBDE-100,
PBDE-153, and PBDE-154 levels but lower
PBDE-99 levels (Table 1). Indoor dust sam-
ples from two U.K. parliamentary buildings
(Santillo et al. 2001) and from houses in the
United Kingdom (Santillo et al. 2003) exhib-
ited similar patterns. PBDE patterns in fish
from the U.K. North Sea (Thomas et al. 2003)
also gave rise to a closely matching profile. U.S.
data suggest a similar profile for foam (Hale
et al. 2002) but a different indoor dust pattern
(Rudel et al. 2003).
London (population > 10 million) contrasts
markedly with Lancaster, a semirural town
(population ~100,000). Pearson correlations of
the logged ΣPCB, ΣPBDE, ΣHCH, ΣDDX,
Article | Contaminants in U.K. breast milk, 2001–2003
Environmental Health Perspectives • VOLUME 112 | NUMBER 10 | July 2004 1089
Figure 1. A comparison (London vs. Lancaster) of the geometric mean levels of (A) PCBs and OCs and (B) PBDEs in breast milk samples obtained from
U.K.-resident women.
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Table 5. Comparison of geometric means [median; range (ng/g lipid)] of PBDE and PCB congeners, and
OCs in breast milk from London and Lancaster regions of the United Kingdom after extraction of milk fat.
Significancea
Contaminant London Lancaster (p-value)
PBDE-47 3.9 (4.6; 1.0–36) 1.8 (2.2; 0.1–17) Yes (0.000)
PBDE-99 0.9 (1.0; ND–12) 0.8 (0.6; ND–6.8) No (0.636)
PBDE-100 0.6 (0.5; 0.1–7.0) 0.5 (0.4; ND–4.5) No (0.186)
PBDE-153 1.4 (1.2; ND-4.9) 1.4 (1.4; ND–3.5) No (0.833)
PBDE-154 0.5 (0.5; ND-2.1) 0.4 (0.3; ND–2.4) No (0.173)
ΣPBDE 7.8 (8.1; 3.1–69) 4.6 (5.0; 0.3–34) Yes (0.006)
PCB-138 41 (45; 6.4–100) 22 (29; 4.2–73) Yes (0.001)
PCB-153 53 (58; 5.6–130) 29 (37; 4.3–100) Yes (0.005)
PCB-180 27 (30; 1.9–120) 15 (20; 1.8–54) Yes (0.024)
ΣPCB 204 (210; 47–530) 110 (140; 26–370) Yes (0.000)
p,p´-DDE 230 (180; 76–1,600) 82 (90; 22–260) Yes (0.000)
ΣDDX 240 (190; 77–2,300) 87 (98; 24–270) Yes (0.000)
HCB 20 (21; 7.6–180) 12 (14; ND–30) Yes (0.003)
β-HCH 20 (19; 5.6–1,500) 10 (13; 1.2–33) Yes (0.002)
ΣHCH 22 (20; 8.6–1,500) 11 (14; 1.2–36) Yes (0.001)
ND, Not detected. For raw data, see Supplemental Material online (http://ehp.niehs.nih.gov/members/2004/6991/
supplemental.pdf).
aAs determined by a t-test after log transformation of the data. 
Figure 2. PCA score plots of milk-extract samples;
t[1] and t[2] are first and second principal compo-
nents, respectively. Black squares represent sam-
ple extracts containing the lowest contaminant
levels (n = 7, all from Lancaster). Blue circles rep-
resent sample extracts containing the highest con-
taminant levels (n = 7, all from London).
*Two sample extracts closely aligned together.
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and HCB levels were examined. ΣPCB signifi-
cantly correlated with ΣPBDE (p < 0.01),
ΣHCH (p < 0.05), ΣDDX (p < 0.01), and
HCB (p < 0.01). ΣDDX also significantly cor-
related with ΣPBDE (p < 0.01), ΣHCH (p <
0.01), and HCB (p < 0.01), whereas ΣPBDE
correlated well with ΣHCH (p < 0.05) and
HCB (p < 0.05). PBDE congeners significantly
correlated (p < 0.01) as follows: PBDE-47 with
PBDE-99, PBDE-100, PBDE-153, and
PBDE-153; PBDE-99 with PBDE-100,
PBDE-153, and PBDE-154; and PBDE-153
with PBDE-154. Such correlation may indicate
that humans are exposed to PBDEs predomi-
nantly via diet, as with PCBs. Higher breast
milk PCB levels are associated with urban
regions (Vartiainen et al. 1998). Contaminant
levels absorbed in food may reflect ambient
contamination (Kalantzi et al. 2001). The fact
that 1H-NMR spectroscopy further demon-
strates these regional differences suggests that
this method may have future potential as a
chemical fingerprinting methodology of
biologic fluids such as breast milk.
We ascertained current contaminant levels
in milk-fat extracts obtained from U.K. breast
milk samples obtained from two sources: a milk
bank in the southeast and a neonatal unit in the
northwest. Breast milk has been hypothesized
to be a surrogate tissue to monitor in vivo expo-
sures to breast epithelial cells (Martin et al.
2001). Epidemiologic studies (Stellman et al.
2000) and experimental studies in rodents
(Schiestl et al. 1997) suggest a role for OCs and
PCBs in cancer causation. Others suggest a lack
of association between exposure to OCs or
PCBs and breast cancer risk (Gammon et al.
2002; Zheng et al. 2000), whereas individual
dioxin-like PCBs may increase risk (Demers
et al. 2002). Breast cancer incidence in these
areas of the United Kingdom is 68 per 100,000
in the southeast versus 64 per 100,000 in the
northwest (Great Britain Department of Health
1998). However, any such associations with
breast cancer incidence or, indeed, any other
disease is difficult in the context of such a small
sample size (n = 54) and in the absence of
prospective follow-up.
Lifetime exposures to OCs, PCBs, or
PBDEs will vary considerably (Angulo et al.
1999), and the effects of fluctuating levels of
endocrine modulators remain to be ascer-
tained (Kalantzi et al. 2004; Yared et al.
2002). Rather than inducing DNA damage
themselves, such agents may enhance the sus-
ceptibility of target cells to other xenobiotics
(Davis et al. 2002). Endocrine disruptors may
bind with the aryl hydrocarbon receptor,
increasing transcription of CYP1A1 (Behnisch
et al. 2001). Such differential regulation by
xenoestrogen mixtures could dramatically
enhance toxicity (Coumoul et al. 2001) and
may also modulate cell cycle events (Dohr
and Abel 1997).
Despite the presence of contaminants in
U.K. breast milk, it must be emphasized that
breast-feeding is protective to the neonate
(Dundaroz et al. 2002; Oddy 2001) and also
appears to confer a protective effect against
breast cancer in the mother (Grover and
Martin 2002). The value of this resource is
that it potentially allows us to noninvasively
analyze ongoing exposures. This work shows
for the first time the presence of PBDEs in
U.K. breast milk obtained from two different
locations and also points to significant
regional differences in contaminants in this
biologic fluid. Future work is required to
ascertain the underlying reasons for these
regional differences and also the biologic
effects of such exposures.
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